Department of Biomaterials (309), Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
J Biomed Mater Res A. 2013 Aug;101(8):2365-73. doi: 10.1002/jbm.a.34531. Epub 2013 Jan 30.
Calcium phosphate cements (CPCs) have been widely used as an alternative to biological grafts due to their excellent osteoconductive properties. Although degradation has been improved by using poly(D,L-lactic-co-glycolic) acid (PLGA) microspheres as porogens, the biological performance of CPC/PLGA composites is insufficient to stimulate bone healing in large bone defects. In this context, the aim of this study was to investigate the effect of incorporating osteopromotive bioactive glass (BG; up to 50 wt %) on setting properties, in vitro degradation behavior and morphological characteristics of CPC/BG and CPC/PLGA/BG. The results revealed that the initial and final setting time of the composites increased with increasing amounts of incorporated BG. The degradation test showed a BG-dependent increasing effect on pH of CPC/BG and CPC/PLGA/BG pre-set scaffolds immersed in PBS compared to CPC and CPC/PLGA equivalents. Whereas no effects on mass loss were observed for CPC and CPC/BG pre-set scaffolds, CPC/PLGA/BG pre-set scaffolds showed an accelerated mass loss compared with CPC/PLGA equivalents. Morphologically, no changes were observed for CPC and CPC/BG pre-set scaffolds. In contrast, CPC/PLGA and CPC/PLGA/BG showed apparent degradation of PLGA microspheres and faster loss of integrity for CPC/PLGA/BG pre-set scaffolds compared with CPC/PLGA equivalents. Based on the present in vitro results, it can be concluded that BG can be successfully introduced into CPC and CPC/PLGA without exceeding the setting time beyond clinically acceptable values. All injectable composites containing BG had suitable handling properties and specifically CPC/PLGA/BG showed an increased rate of mass loss. Future investigations should focus on translating these findings to in vivo applications.
磷酸钙骨水泥 (CPC) 因其出色的骨诱导性能而被广泛用作生物移植物的替代品。尽管通过使用聚(D,L-乳酸-共-乙醇酸)(PLGA)微球作为成孔剂来改善降解性能,但 CPC/PLGA 复合材料的生物学性能不足以刺激大骨缺损中的骨愈合。在这种情况下,本研究的目的是研究掺入促骨玻璃(BG;高达 50wt%)对 CPC/BG 和 CPC/PLGA/BG 的凝固性能、体外降解行为和形态特征的影响。结果表明,复合材料的初始和最终凝固时间随掺入 BG 的量的增加而增加。降解试验表明,与 CPC 和 CPC/PLGA 等效物相比,BG 依赖性地增加了浸入 PBS 中的 CPC/BG 和 CPC/PLGA/BG 预成型支架的 pH 值。而 CPC 和 CPC/BG 预成型支架的质量损失没有影响,CPC/PLGA/BG 预成型支架的质量损失则比 CPC/PLGA 等效物更快。形态上,CPC 和 CPC/BG 预成型支架没有变化。相比之下,CPC/PLGA 和 CPC/PLGA/BG 显示出 PLGA 微球的明显降解,并且与 CPC/PLGA 等效物相比,CPC/PLGA/BG 预成型支架的完整性更快丧失。基于目前的体外结果,可以得出结论,BG 可以成功地引入 CPC 和 CPC/PLGA 中,而不会使凝固时间超过临床可接受的值。所有含有 BG 的可注射复合材料均具有合适的处理性能,特别是 CPC/PLGA/BG 显示出更快的质量损失率。未来的研究应集中在将这些发现转化为体内应用。